Alphavirus-based cytomegalovirus vaccines

Details for Australian Patent Application No. 2004257214 (hide)

Owner Alphavax, Inc.

Inventors Chulay, Jeffrey D.; Olmsted, Robert A.; Morris, John S.; Dryga, Sergey; Reap, Elizabeth A.

Agent Griffith Hack

Pub. Number AU-B-2004257214

PCT Pub. Number WO2005/007689

Priority 60/486,501 11.07.03 US

Filing date 8 July 2004

Wipo publication date 27 January 2005

Acceptance publication date 22 April 2010

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/045 (2006.01) Peptides having more than 20 amino acids

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

Event Publications

15 December 2005 PCT application entered the National Phase

  PCT publication WO2005/007689 Priority application(s): WO2005/007689

22 April 2010 Application Accepted

  Published as AU-B-2004257214

19 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004257220-Novel azaheterocyclic amides useful for treating pain

2004257212-Pivotable shaving cartridge and razor including same